VC  Kairos Ventures

https://www.kairosventures.com/





     Office Locations:

9440 S. Santa Monica Blvd. #710
Beverly Hills, CA 90210
Phone: 310-271-1866

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.
 

Stages:

  • Early
  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Founded in 2015 by Jim Demetriades, Kairos Ventures invests in early, often during the formative stages of a company, and works closely with the world's leading scientist to commercialize their technologies. Depending on the stage of development and the capital requirements of each venture, typical investments are between $150,000 and $20 million in companies with a focus in hard sciences. In addition to providing early-stage capital, the firm leverages their expertise and network of professionals specializing in all disciplines required to build a successful company, including legal, finance, marketing, operations, business development and HR. The firm announced (June 2013) the close of its third fund with capital commitments of $58 million. Since its inception, Kairos has invested in over 55 companies. Fund III has made 27 investments.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Alex Andrianopoulos Chief R&D Officer
    Jim Demetriades CEO and Founder
    Josh Palmer PhD Principal
    Stephanie Kawecki PhD Associate
    Todd Thomson Chief Operating and Financial Officer

     

    Portfolio companies include:


      1200 Pharma


      3D Bio


      Actinia


      Actuate Therapeutics
        web link


      Amorphology


      Axial Biotherapeutics
        web link


      BabySparks


      Blueprint Income
        web link


      Clair
        web link


      CytoDel


      DEARhealth


      Foldax


      GuRu Wireless
        web link


      Holoclara


      iBeat
        web link


      Linnaeus Therapeutics
        web link


      Little Spoon
        web link


      New Age Meats


      OrthoFX
        web link


      Pillar


      PolyCera Membranes
        web link


      Provivi


      Rhino


     

    Recent News: